{"id":697,"date":"2015-03-24T22:21:51","date_gmt":"2015-03-24T21:21:51","guid":{"rendered":"https:\/\/blogdelarechercheclinique.com\/?p=697"},"modified":"2025-05-21T12:06:56","modified_gmt":"2025-05-21T10:06:56","slug":"risk-based-monitoring","status":"publish","type":"post","link":"https:\/\/blogdelarechercheclinique.com\/en\/risk-based-monitoring\/","title":{"rendered":"The risk-based monitoring: a new method for quality control?"},"content":{"rendered":"

The risk-based monitoring: what is it?<\/strong><\/p>\n

In a few years, we are seeing a real change in how to make a clinical trial monitoring at the international level.<\/p>\n

Indeed, a new risk-based approach was integrated in Good Clinical Practice (GCP, ICH GCP, Section 5.1) and in the European Directive 2005\/28 \/ EC. We talk about \u00ab\u00a0Clinical trials monitoring adapted to\u00a0risk\u00a0\u00bb (or \u00ab\u00a0risk-based monitoring\u00a0\u00bb).<\/p>\n

In this article we will explain you this concept that may seem a bit complicated at first.<\/p>\n

<\/p>\n

1. Regulatory context<\/h2>\n

In Europe, GCPs were imposed on all the clinical trials of a drug for human use by European Directives 2001\/20 \/ EC and 2005\/28 \/ EC (The GCPs were transposed in French law by the decision of 24 November 2006). They will incorporate many concepts, including that of monitoring.<\/p>\n

Definition of monitoring (from the decision of November 2006): \"Activity of monitoring the progress of biomedical research and ensuring that it is conducted and the data is\ncollected and reported according to the protocol, to standards operating procedures, to   the  GCPs and the legislative and to the regulatory provisions in force. \"<\/pre>\n
The monitoring of all source folders onsite has been considered as the standard approach applied by the CRAs for a long time. However, in a\u00a0few years, a new trend is emerging.<\/p>\n
Indeed in 2013, the FDA (Food and Drug Administration) and the EMA (European Medicines Agency) published respectively a guide (\u00a0\u00bb\u00a0Oversight of clinical investigations – a risk based approach to monitoring<\/em>\u00a0<\/a>\u00bb and\u00a0\u00ab Electronic source data in clinical investigations<\/a>\u00a0\u00bb) and a reflection text ( \u00ab\u00a0Reflection paper on risk based quality management in clinical trials<\/em>\u00ab\u00a0, downloadable\u00a0here<\/a>),\u00a0encouraging the pharmaceutical industry to consider a new monitoring approach, the \u00ab\u00a0risk-based monitoring\u00a0\u00bb (RBM)<\/strong><\/a>.<\/p>\n
This approach was created after\u00a0significant deficiencies in the clinical trials monitoring despite 100% SDV (Source Data Verification) on site. The FDA and EMA have recommended a more centralized monitoring approach, including many performance indicators to identify problems on the research site, and to limit the amount of performed SDV.<\/p>\n
The RBM therefore incorporates the concept of risk, incurred by the participant, and is to adapt the pace of monitoring visits of the CRA based on the risk.<\/p>\n
\"Risk-based2. The\u00a0<\/strong>Risk Based Monitoring (RBM), what does it consist of?<\/h2>\n
Unlike \u201cstandard\u201d monitoring which checks\u00a0100% of the data source and identify errors of data transcription in paper or electronic CRF, the Risk Based Monitoring wishes to optimize and lighten\u00a0the monitoring.<\/p>\n
The intensity of the on-site data checking\u00a0will then be adapted to the level of risk, predetermined from the beginning\u00a0of the study in the ‘Risk management plan. \u201cThis will allow, among others, to optimize the monitoring on site, so to reduce the time spent in the center, and therefore, the cost attributed to the monitoring. (Almost 30% of the budget of a study is devoted to monitoring!).
\nThis happens notably by the \u00ab\u00a0Remote monitoring\u00a0\u00bb (an article was written about it, you can see it again on the blog by clicking this link: https:\/\/blogdelarechercheclinique.com\/remote-monitoring\/<\/a>).<\/p>\n
Note that the consents audits, eligibility criteria, and safety data (EIG) remain unchanged during the monitoring on site.<\/p>\n
In its guide, the FDA encourages promoters to \u00ab\u00a0make global statistical analysis of the study data to identify sites that are aberrant compared to others.\u00a0\u00bb In other words, the promoter can identify centers which data are significantly different from others through statistical algorithms. The promoter will seek to detect incompatible information generated by a center with basing on the data produced by all the other sites participating in the clinical trial<\/p>\n
For example, when\u00a0a center makes a mistakes over several patients, or, when on the opposite, a center never makes mistakes, the promoter must be able to identify it with his software. Thus, the promoter assesses the consistency of data from each center and detects abnormal data to identify specific problems of each center.<\/p>\n
Thereby, identifying data gaps, the promoter may trigger a monitoring visit on site, or orientate the CRA on this or that issue to verify at the next visit on site.<\/p>\n
Prevent and identify risks (error detection, carelessness, fraud, falsification) as soon as possible thanks to\u00a0the statistics and then can anticipate and correct the problem before it gets worse.<\/p>\n
3. <\/strong>Application of RBM in the AP-HP (Public Hospitals of Paris)<\/h2>\n
Since 2003, the AP-HP applies risk-based monitoring<\/strong><\/a>, depending on the type of clinical trial (with or without medication) and according to the phase of the concerned study, particularly for budgetary reasons.<\/p>\n
Click here<\/a>, You will find below 3 grids used by the AP-HP<\/a>\u00a0to set the monitor level (A, B, C, or D; D being the highest level) of a clinical trial:<\/p>\n
4. Skills required for the CRA<\/strong><\/p>\n
In RBM, the CRA will incorporate the review of data quality as a whole. For this, the CRA will have to improve and \/ or strengthen some of his skills.
\n– Use of statistical software to identify data gaps;
\n– Interpreting these differences, that is to say, to have an overview on data from the study: to evaluate all the data of a site compared to other sites to see if errors are recurrent and thus correct them quickly.
\n– Perform the monitoring and remotely (by telephone, remote monitoring, …)
\n– Write tools to help decision making for different types of risk
\n– Write a \u00ab\u00a0Risk management Plan\u00a0\u00bb<\/p>\n
The initial and continuing training in clinical research<\/strong><\/a> will have to adapt to allow CRA to acquire these new skills.<\/p>\n
Conclusion\u00a0:
\n<\/strong>It has been demonstrated\u00a0that a high frequency of monitoring on site does not necessarily lead to a better quality of the trail\u00a0data. By providing more clarity and efficiency, the Monitoring risk-based will be the new standard to be adopted by all CRAs. The new generation of CRAs will have to develop new skills to meet to perform this type of monitoring under the right conditions: proactivity, statistical and analytical skills, etc.<\/p>\n
The integration of statistical software in the risk-based monitoring<\/strong> will be essential to the promoter to prevent possible risks, and to help him improving the effectiveness of his monitoring process but also the quality and reliability of clinical data.<\/p>\n
Sources\u00a0:<\/p>\n
– Journal of clinical research<\/strong> best practices, Vol. 9, N\u00b09, September 2013, \u00ab\u00a0Adaptive monitoring\u00a0: Risk-based monitoring and beyond\u00a0\u00bb by Michael Rosenberg
\n<\/a>– \u00ab\u00a0Competencies for the changing role of the clinical study monitor\u00a0: implementing a risk-based approach to monitoring\u00a0<\/a>\u00bb, April 29, 2014 by Charlene Stubbs et\u00a0al.
\n– http:\/\/www.cluepoints.com\/solutions\/reduce-regulatory-submission-risk
\n– http:\/\/www.fcrin.org\/<\/a><\/p>\n
If you liked this article, I invite you to click on \u00ab\u00a0I like\u00a0\u00bb or share with your CRA colleagues and friends and project Manager<\/p>\n
Also, visit Pharmaspecific website : \u00a0http:\/\/www.pharmaspecific.fr<\/a>\u00a0and discover our activities.<\/p>\n
You can visit the Facebook page of \u00ab\u00a0blog de la recherche clinique\u00a0\u00bb\u00a0and the\u00a0\u00ab\u00a0Pharmaspecific\u00a0\u00bb\u00a0and click on \u00ab\u00a0I like\u00a0\u00bb to support us.<\/p>\n
See\u00a0\u00ab\u00a0Pharmaspecific Linkedin<\/a>\u00a0\u00bb\u00a0and\u00a0\u00ab\u00a0Vanessa Montanari Linkedin<\/a>\u00a0\u00bb \u00a0on\u00a0LinkedIn for more relevant news on clinical researches.<\/p>\n
See us as well\u00a0Pharmaspecific Viadeo<\/a>\u00a0and\u00a0Vanessa Viadeo<\/a>.<\/p>\n
You can also subscribe on the blog’s newsletter we will keep you posted once a new article is published.{:}<\/p>","protected":false},"excerpt":{"rendered":"
In a few years, we are seeing a real change in how to make a clinical trial monitoring at the international level. In this article we will explain you this concept that may seem a bit complicated at first.<\/p>","protected":false},"author":4,"featured_media":14018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"facebook_122143508198123560_331463380343150":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","_sitemap_exclude":false,"_sitemap_priority":"","_sitemap_frequency":"","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[449],"tags":[16,92,155,103,8,157,158],"class_list":{"0":"post-697","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-pratiquer-le-metier-dattache-de-recherche-clinique","8":"tag-arc","9":"tag-essai-clinique","10":"tag-etude-clinique","11":"tag-monitoring","12":"tag-recherche-clinique","13":"tag-risk-based-monitoring","14":"tag-statistiques"},"translation":{"provider":"WPGlobus","version":"3.0.2","language":"en","enabled_languages":["fr","en"],"languages":{"fr":{"title":true,"content":true,"excerpt":true},"en":{"title":false,"content":false,"excerpt":false}}},"yoast_head":"\nThe risk-based monitoring: what is it?<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogdelarechercheclinique.com\/en\/risk-based-monitoring\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The risk-based monitoring: a new method for quality control? -\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogdelarechercheclinique.com\/en\/risk-based-monitoring\/\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/blogdelarechercheclinique\" \/>\n<meta property=\"article:published_time\" content=\"2015-03-24T21:21:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-21T10:06:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png\" \/>\n\t<meta property=\"og:image:width\" content=\"698\" \/>\n\t<meta property=\"og:image:height\" content=\"696\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Vanessa Montanari\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Vanessa Montanari\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/\"},\"author\":{\"name\":\"Vanessa Montanari\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/13ee3f7a1251afe7e98918a482685938\"},\"headline\":\"The risk-based monitoring: a new method for quality control?\",\"datePublished\":\"2015-03-24T21:21:51+00:00\",\"dateModified\":\"2025-05-21T10:06:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/\"},\"wordCount\":1119,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1\",\"keywords\":[\"ARC\",\"essai clinique\",\"Etude clinique\",\"monitoring\",\"recherche clinique\",\"RIsk-based monitoring\",\"Statistiques\"],\"articleSection\":[\"Pratiquer le m\u00e9tier d'Attach\u00e9 de recherche clinique\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/\",\"url\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/\",\"name\":\"The risk-based monitoring: what is it?\",\"isPartOf\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1\",\"datePublished\":\"2015-03-24T21:21:51+00:00\",\"dateModified\":\"2025-05-21T10:06:56+00:00\",\"description\":\"The risk-based monitoring was integrated in Good Clinical Practice. In this article we will explain you this concept.\",\"breadcrumb\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1\",\"width\":698,\"height\":696,\"caption\":\"Risk-based monitoring\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/blogdelarechercheclinique.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The risk-based monitoring: a new method for quality control?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#website\",\"url\":\"https:\/\/blogdelarechercheclinique.com\/\",\"name\":\"Blog de la recherche clinique\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blogdelarechercheclinique.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#organization\",\"name\":\"Blog de la recherche clinique\",\"url\":\"https:\/\/blogdelarechercheclinique.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1\",\"width\":512,\"height\":512,\"caption\":\"Blog de la recherche clinique\"},\"image\":{\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/blogdelarechercheclinique\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/13ee3f7a1251afe7e98918a482685938\",\"name\":\"Vanessa Montanari\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ddf428208f542d6c2239ace6606ebe9beb71049642a9c784967f23e4e76e8efc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ddf428208f542d6c2239ace6606ebe9beb71049642a9c784967f23e4e76e8efc?s=96&d=mm&r=g\",\"caption\":\"Vanessa Montanari\"},\"url\":\"https:\/\/blogdelarechercheclinique.com\/en\/author\/vanessa\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The risk-based monitoring: what is it?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogdelarechercheclinique.com\/en\/risk-based-monitoring\/","og_locale":"en_US","og_type":"article","og_title":"The risk-based monitoring: a new method for quality control? -","og_url":"https:\/\/blogdelarechercheclinique.com\/en\/risk-based-monitoring\/","article_publisher":"https:\/\/www.facebook.com\/blogdelarechercheclinique","article_published_time":"2015-03-24T21:21:51+00:00","article_modified_time":"2025-05-21T10:06:56+00:00","og_image":[{"width":698,"height":696,"url":"https:\/\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png","type":"image\/png"}],"author":"Vanessa Montanari","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Vanessa Montanari","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#article","isPartOf":{"@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/"},"author":{"name":"Vanessa Montanari","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/13ee3f7a1251afe7e98918a482685938"},"headline":"The risk-based monitoring: a new method for quality control?","datePublished":"2015-03-24T21:21:51+00:00","dateModified":"2025-05-21T10:06:56+00:00","mainEntityOfPage":{"@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/"},"wordCount":1119,"commentCount":1,"publisher":{"@id":"https:\/\/blogdelarechercheclinique.com\/#organization"},"image":{"@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1","keywords":["ARC","essai clinique","Etude clinique","monitoring","recherche clinique","RIsk-based monitoring","Statistiques"],"articleSection":["Pratiquer le m\u00e9tier d'Attach\u00e9 de recherche clinique"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/","url":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/","name":"The risk-based monitoring: what is it?","isPartOf":{"@id":"https:\/\/blogdelarechercheclinique.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage"},"image":{"@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1","datePublished":"2015-03-24T21:21:51+00:00","dateModified":"2025-05-21T10:06:56+00:00","description":"The risk-based monitoring was integrated in Good Clinical Practice. In this article we will explain you this concept.","breadcrumb":{"@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#primaryimage","url":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1","contentUrl":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1","width":698,"height":696,"caption":"Risk-based monitoring"},{"@type":"BreadcrumbList","@id":"https:\/\/blogdelarechercheclinique.com\/risk-based-monitoring\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/blogdelarechercheclinique.com\/"},{"@type":"ListItem","position":2,"name":"The risk-based monitoring: a new method for quality control?"}]},{"@type":"WebSite","@id":"https:\/\/blogdelarechercheclinique.com\/#website","url":"https:\/\/blogdelarechercheclinique.com\/","name":"Blog de la recherche clinique","description":"","publisher":{"@id":"https:\/\/blogdelarechercheclinique.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogdelarechercheclinique.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogdelarechercheclinique.com\/#organization","name":"Blog de la recherche clinique","url":"https:\/\/blogdelarechercheclinique.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1","contentUrl":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/04\/cropped-BLOG-logo.png?fit=512%2C512&ssl=1","width":512,"height":512,"caption":"Blog de la recherche clinique"},"image":{"@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/blogdelarechercheclinique"]},{"@type":"Person","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/13ee3f7a1251afe7e98918a482685938","name":"Vanessa Montanari","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogdelarechercheclinique.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ddf428208f542d6c2239ace6606ebe9beb71049642a9c784967f23e4e76e8efc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ddf428208f542d6c2239ace6606ebe9beb71049642a9c784967f23e4e76e8efc?s=96&d=mm&r=g","caption":"Vanessa Montanari"},"url":"https:\/\/blogdelarechercheclinique.com\/en\/author\/vanessa\/"}]}},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1","jetpack-related-posts":[{"id":14016,"url":"https:\/\/blogdelarechercheclinique.com\/en\/le-risk-based-monitoring-une-nouvelle-approche-du-controle-qualite-2\/","url_meta":{"origin":697,"position":0},"title":"Le Risk-based monitoring, une nouvelle approche du contr\u00f4le qualit\u00e9","author":"Vanessa Montanari","date":"24 March 2015","format":false,"excerpt":"Depuis quelques ann\u00e9es, nous assistons \u00e0 un v\u00e9ritable changement concernant la fa\u00e7on de r\u00e9aliser le monitoring d\u2019un essai clinique, et ce, \u00e0 l\u2019\u00e9chelle internationale. Dans cet article, nous te proposons de t\u2019expliquer cette notion qui peut para\u00eetre un peu compliqu\u00e9e de prime abord.","rel":"","context":"In "Pratiquer le m\u00e9tier d'Attach\u00e9 de recherche clinique"","block_context":{"text":"Pratiquer le m\u00e9tier d'Attach\u00e9 de recherche clinique","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/pratiquer-le-metier-dattache-de-recherche-clinique\/"},"img":{"alt_text":"Risk-based monitoring","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/risk-based.png?fit=698%2C696&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":1357,"url":"https:\/\/blogdelarechercheclinique.com\/en\/les-ich-sur-le-bout-des-doigts\/","url_meta":{"origin":697,"position":1},"title":"The ICH E6 (R2) on the fingertips","author":"Vanessa Montanari","date":"21 October 2015","format":false,"excerpt":"Do not worry, it is currently a draft version of the \"ICH E6 R2\" addendum to the Guidelines on GCP (= Good Clinical Practice). It is a \"draft\" and updated version for public consultation. The latest version dates back almost 20 years (1996!)","rel":"","context":"In "Les r\u00e8glementaires"","block_context":{"text":"Les r\u00e8glementaires","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/reglementaires\/"},"img":{"alt_text":"ICH E6 (R2)","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/10\/ICH-E6-R2.png?fit=823%2C582&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/10\/ICH-E6-R2.png?fit=823%2C582&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/10\/ICH-E6-R2.png?fit=823%2C582&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/10\/ICH-E6-R2.png?fit=823%2C582&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":16298,"url":"https:\/\/blogdelarechercheclinique.com\/en\/lich-e6-r3-comment-le-comprendre-avec-transcelerate\/","url_meta":{"origin":697,"position":2},"title":"Navigating the ICH E6(R3) Transition: Expert Insights & Tools","author":"Virginie Smartelia","date":"2 March 2026","format":false,"excerpt":"{:fr} La version finale de l\u2019ICH E6(R3) change les r\u00e8gles du jeu dans la recherche clinique.Plus flexible, plus logique et mieux adapt\u00e9e \u00e0 l\u2019utilisation de l\u2019outil num\u00e9rique, elle pousse chacun \u00e0 revoir ses habitudes. Mais soyons honn\u00eates, entre les annexes, les nouveaux concepts et les obligations de conformit\u00e9, ce n\u2019est\u2026","rel":"","context":"In "Non class\u00e9"","block_context":{"text":"Non class\u00e9","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/non-classe\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Image.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Image.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2026\/03\/Image.png?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":15932,"url":"https:\/\/blogdelarechercheclinique.com\/en\/attache-de-recherche-clinique-bienvenue-en-2025\/","url_meta":{"origin":697,"position":3},"title":"Clinical Research Associate on 2025","author":"Virginie Smartelia","date":"27 October 2025","format":false,"excerpt":"{:fr} Et si l'ARC de 2025 n'avait plus grand-chose \u00e0 voir avec celui d'il y a cinq ans ? Digitalisation des essais, outils d'IA, r\u00e9glementations renforc\u00e9es\u2026 Le m\u00e9tier se red\u00e9finit et s'adapter devient un imp\u00e9ratif. L'IA au c\u0153ur des essais cliniques : un nouveau r\u00f4le pour l'ARC L'intelligence artificielle est\u2026","rel":"","context":"In "Actualit\u00e9s de la recherche clinique"","block_context":{"text":"Actualit\u00e9s de la recherche clinique","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/actualites-de-la-recherche-clinique\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":843,"url":"https:\/\/blogdelarechercheclinique.com\/en\/study-bmr-routine-care\/","url_meta":{"origin":697,"position":4},"title":"Your study : BMR or routine care?","author":"Vanessa Montanari","date":"17 June 2015","format":"image","excerpt":"Today, the typology of clinical research studies is based on the Code of Public Health. Despite its publication in the Official newspaper\u00a0in March 2012, the Jard\u00e9 law that planned, among other things, a new typology of research based on risk, is still not implemented and is suspended to the publication\u2026","rel":"","context":"In "Devenir Attach\u00e9 de recherche clinique: formation, financement"","block_context":{"text":"Devenir Attach\u00e9 de recherche clinique: formation, financement","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/devenir-attache-de-recherche-clinique\/"},"img":{"alt_text":"URC CIC","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/06\/URC-CIC-Necker-Cochin.png?fit=794%2C502&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/06\/URC-CIC-Necker-Cochin.png?fit=794%2C502&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/06\/URC-CIC-Necker-Cochin.png?fit=794%2C502&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2015\/06\/URC-CIC-Necker-Cochin.png?fit=794%2C502&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":735,"url":"https:\/\/blogdelarechercheclinique.com\/en\/clinical-research-medical-device\/","url_meta":{"origin":697,"position":5},"title":"Clinical research and medical devices, how to go about it?","author":"Vanessa Montanari","date":"7 May 2015","format":false,"excerpt":"Clinical research has become essential for medical device companies. How to go about it to mount his clinical investigation? What are the specific characteristics, texts and reference guides to be considered?","rel":"","context":"In "Actualit\u00e9s de la recherche clinique"","block_context":{"text":"Actualit\u00e9s de la recherche clinique","link":"https:\/\/blogdelarechercheclinique.com\/en\/category\/actualites-de-la-recherche-clinique\/"},"img":{"alt_text":"La recherche clinique sur les dispositifs m\u00e9dicaux","src":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/dispositif-medicaux.png?fit=853%2C565&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/dispositif-medicaux.png?fit=853%2C565&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/dispositif-medicaux.png?fit=853%2C565&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/blogdelarechercheclinique.com\/blog-contenu\/uploads\/2024\/05\/dispositif-medicaux.png?fit=853%2C565&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts\/697","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/comments?post=697"}],"version-history":[{"count":4,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts\/697\/revisions"}],"predecessor-version":[{"id":14027,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/posts\/697\/revisions\/14027"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/media\/14018"}],"wp:attachment":[{"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/media?parent=697"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/categories?post=697"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogdelarechercheclinique.com\/en\/wp-json\/wp\/v2\/tags?post=697"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}